Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.512 EUR | -0.26% | +0.27% | -41.03% |
Business Summary
Sales per Business
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
In Vitro Diagnostic - Products
95.9
%
| 0 | 7.5 % | 0 | 95.9 % | -.--% |
Licensing
4.1
%
| 0 | 0.4 % | 0 | 4.1 % | -9.09% |
Sales per region
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
North America
54.2
%
| 0 | 4.8 % | 0 | 54.2 % | -11.45% |
Europe
38.6
%
| 0 | 3.0 % | 0 | 38.6 % | -1.06% |
Asia
7.2
%
| 6 | 92.2 % | 0 | 7.2 % | -99.39% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 875,150 | 584,339 ( 66.77 %) | 0 | 66.77 % |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-18.88% | 11.03B | |
+53.75% | 3.5B | |
-32.50% | 2.23B | |
-14.31% | 2.16B | |
-26.83% | 1.54B | |
+28.55% | 1.12B | |
-3.28% | 737M | |
-23.50% | 477M | |
-43.27% | 411M |
- Stock Market
- Equities
- ECX Stock
- ECX Stock
- Company Epigenomics AG